| 000 | 01721 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515153806.0 | ||
| 264 | 0 | _c20090624 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1535-9484 | ||
| 024 | 7 |
_a10.1074/mcp.M800454-MCP200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNilsson, Anna | |
| 245 | 0 | 0 |
_aStriatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. _h[electronic resource] |
| 260 |
_bMolecular & cellular proteomics : MCP _cMay 2009 |
||
| 300 |
_a1094-104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCholecystokinin _xchemistry |
| 650 | 0 | 4 |
_aChromogranin B _xchemistry |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnkephalins _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeostriatum _xmetabolism |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinson Disease _xenzymology |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aPostmortem Changes |
| 650 | 0 | 4 |
_aProtein Precursors _xchemistry |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSomatostatin _xchemistry |
| 650 | 0 | 4 | _aTissue Extracts |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aFälth, Maria | |
| 700 | 1 | _aZhang, Xiaoqun | |
| 700 | 1 | _aKultima, Kim | |
| 700 | 1 | _aSköld, Karl | |
| 700 | 1 | _aSvenningsson, Per | |
| 700 | 1 | _aAndrén, Per E | |
| 773 | 0 |
_tMolecular & cellular proteomics : MCP _gvol. 8 _gno. 5 _gp. 1094-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/mcp.M800454-MCP200 _zAvailable from publisher's website |
| 999 |
_c18580347 _d18580347 |
||